Endo terminates $190M deal for sterile injectable player

28th February 2019 Uncategorised 0

Endo and its Par sterile injectables subsidiaries on Wednesday said a $190 million agreement to buy Somerset Therapeutics had been terminated without penalties because it was taking too long to complete.

More: Endo terminates 0M deal for sterile injectable player
Source: fierce